Kerecis Highlights Innovative Fish-Skin Technology for Wound Care
Kerecis is making waves in the medical community by participating in the annual Symposium on Advanced Wound Care (SAWC). As a pioneer in the use of fish-skin for tissue regeneration and protection, Kerecis has been showcasing the remarkable scientific advancements surrounding fish-skin grafts. This innovative approach lends a unique advantage in treating challenging wounds, making a significant impact on patient recovery rates.
Understanding the Advantages of Fish-Skin Grafts
Fish-skin grafts symbolize a cutting-edge therapeutic pathway for advanced wound care. Kerecis is using its platform at SAWC to engage with healthcare professionals and share knowledge about how this grafting technique works. The science behind these grafts is particularly compelling for patients with severe wounds that are often difficult to close and heal.
Key Presentations and Workshops
Kerecis is conducting several sessions aimed at educating attendees about the efficacy of fish-skin grafts. One notable session focuses on the treatment of diabetic foot ulcers, which are notorious for complications. On a recent session, Kerecis medical experts shared groundbreaking research during an industry-supported presentation.
Hands-On Learning Experience
In addition, Kerecis is holding a practical workshop that emphasizes real-world application. Here, participants will learn how to assess and manage lower extremity wounds effectively. With well-structured demonstrations, attendees will gain insights into advanced applications of Kerecis products like SurgiBind®, GraftGuide®, MariGen®, and Shield™.
Culture and Networking Opportunities
The SAWC event also provides networking opportunities that blend professional development with cultural exploration. One highlight is the “Taste of Iceland” event, where participants can delve into Icelandic culture while connecting with Kerecis innovations.
Promising Case Studies and Research Updates
Alongside these interactive experiences, 50 posters showcasing recent advancements and case studies involving Kerecis products will be presented. This session promises to inform healthcare providers of the latest findings and how Kerecis is at the forefront of wound care technology.
About Kerecis
Founded by Fertram Sigurjonsson, Kerecis specializes in developing fish-skin and fatty acid products specifically designed for cellular therapy and tissue protection. Their innovative materials are patented and designed to mitigate disease transfer risks while optimizing healing processes. Kerecis is distinct in the industry as the sole global manufacturer of medical supplies featuring intact fish skin and enjoys a fast-growing market presence in the U.S. biologics skin domain.
Utilizing sustainably sourced Icelandic fish and renewable energy, Kerecis adheres to the UN Sustainable Development Goals in its operations. The company, now part of Coloplast, continues to expand its reach and influence in the healthcare sector, supporting various medical applications.
Frequently Asked Questions
What is Kerecis known for?
Kerecis specializes in fish-skin products that promote tissue regeneration and protection, particularly in wound care.
Where is Kerecis presenting its research?
Kerecis is presenting at the Symposium on Advanced Wound Care (SAWC), currently ongoing.
What are the benefits of fish-skin grafts?
Fish-skin grafts accelerate healing, reduce infection risks, and are particularly effective for difficult-to-treat wounds.
How does Kerecis support sustainability?
Kerecis uses sustainably sourced fish and renewable energy in its manufacturing processes, aligning with global sustainable development goals.
Can healthcare professionals learn more about Kerecis products?
Yes, healthcare professionals can visit Kerecis's website for detailed information and research on its products and applications.
